We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.95B
AUM Growth
-$232M
Cap. Flow
-$467M
Cap. Flow %
-9.44%
Top 10 Hldgs %
11.79%
Holding
1,100
New
153
Increased
294
Reduced
399
Closed
191

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$28.6M
2
INTU icon
Intuit
INTU
+$27.6M
3
EA icon
Electronic Arts
EA
+$23.2M
4
QCOM icon
Qualcomm
QCOM
+$22.5M
5
CVX icon
Chevron
CVX
+$19.1M

Sector Composition

Rank Sector Weight
1 Technology 20.09%
2 Financials 17.69%
3 Healthcare 13.21%
4 Industrials 12.31%
5 Consumer Discretionary 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIZ icon
751
First Business Financial Services
FBIZ
$562M
$255K 0.01%
9,830
FMBI
752
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$252K 0.01%
10,660
+500
+5% +$12.2K
EVRI
753
DELISTED
Everi Holdings
EVRI
$250K 0.01%
52,200
-200
-0.4% -$653
TBHC
754
DELISTED
The Brand House Collective
TBHC
$250K 0.01%
20,194
+9,555
+90% +$120K
LION
755
DELISTED
Fidelity Southern Corporation
LION
$248K 0.01%
+11,100
New +$258K
BMRC icon
756
Bank of Marin Bancorp
BMRC
$466M
$247K 0.01%
7,680
PTCT icon
757
PTC Therapeutics
PTCT
$6.37B
$247K 0.01%
25,060
-3,710
-13% -$44.9K
NNA
758
DELISTED
Navios Maritime Acquisition Corporation
NNA
$247K 0.01%
9,566
+1,560
+19% +$42.8K
NCOM
759
DELISTED
National Commerce Corporation
NCOM
$247K 0.01%
+6,760
New +$250K
KMG
760
DELISTED
KMG Chemicals Inc
KMG
$244K ﹤0.01%
5,300
PCMI
761
DELISTED
PCM, Inc
PCMI
$243K ﹤0.01%
8,660
-7,920
-48% -$202K
TTC icon
762
Toro Company
TTC
$8.93B
$241K ﹤0.01%
3,860
-61,340
-94% -$3.66M
CLAR icon
763
Clarus
CLAR
$125M
$240K ﹤0.01%
44,196
-1,305
-3% -$7.3K
STC icon
764
Stewart Information Services
STC
$2.05B
$239K ﹤0.01%
5,420
PFNX
765
DELISTED
Pfenex Inc.
PFNX
$235K ﹤0.01%
40,443
+19,500
+93% +$147K
DVA icon
766
DaVita
DVA
$15.1B
$232K ﹤0.01%
3,420
-990
-22% -$65.5K
MSL
767
DELISTED
Midsouth Bancorp, Inc.
MSL
$232K ﹤0.01%
+15,191
New +$219K
HUN icon
768
Huntsman Corp
HUN
$2.24B
$231K ﹤0.01%
+9,410
New +$202K
NERV icon
769
Minerva Neurosciences
NERV
$188M
$231K ﹤0.01%
3,563
PRK icon
770
Park National Corp
PRK
$3.41B
$230K ﹤0.01%
2,186
+220
+11% +$24.1K
VWR
771
DELISTED
VWR Corporation
VWR
$228K ﹤0.01%
8,080
-68,470
-89% -$1.83M
CRIS icon
772
Curis
CRIS
$9.53M
$223K ﹤0.01%
+40
New +$222K
CLDX icon
773
Celldex Therapeutics
CLDX
$2.77B
$222K ﹤0.01%
+4,107
New +$214K
LEE icon
774
Lee Enterprises
LEE
$166M
$222K ﹤0.01%
+8,554
New +$243K
NL icon
775
NLI Holdings
NL
$284M
$222K ﹤0.01%
34,405

Similar funds

Jacobs Levy Equity Management's Q1 2017 Portfolio in Review

As of Q1 2017, Jacobs Levy Equity Management held 1,100 positions worth $4.95B, down 4.5% from $5.18B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $467M in Q1 2017, closing 191 positions and reducing 399 holdings. Its most notable exit was VMware, Inc, an estimated $22.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Intuit worth $26.7M.

  • Jacobs Levy Equity Management's largest Q1 2017 buy was Intuit: 229,923 shares worth $26.7M.
  • Jacobs Levy Equity Management added most to Celgene Corp in Q1 2017, an estimated $28.6M increase.
  • Jacobs Levy Equity Management's biggest Q1 2017 reduction was Amgen, cutting an estimated $41.2M.
  • Jacobs Levy Equity Management fully exited VMware, Inc in Q1 2017, selling an estimated $22.6M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $4.95B portfolio in Q1 2017.
  • Jacobs Levy Equity Management opened 153 new positions and closed 191 in Q1 2017.
  • Jacobs Levy Equity Management's portfolio value fell 4.5% quarter-over-quarter to $4.95B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.